drug
as of 2026-07-01Tolcapone
MeSH D000077867
at a glance
small molecule
Pre-approval / investigational in the US
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia
NCT06387771Phase 2Unknown
Clinical Trial of Tolcapone for Cognition in Schizophrenia
NCT00044083Phase 2Terminated
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
KOL
Jose A Apud, M.D.
personKOL score —
Patricio Molero, MD, PhD
personKOL score —